ICON issues 2025 guidance, stock slides 8%
ICON (NASDAQ:ICLR) stock fell 8% early Tuesday after it issued financial guidance for 2025. The clinical research ...
TD Cowen cuts ICON stock price target to $254, maintains Buy rating
TD Cowen adjusted its financial outlook for ICON plc (NASDAQ:ICLR), a global provider of drug development solutions and services to the pharmaceutical, biotechnology, and medical device industries.
Fabbaloo12d
Layoffs at ICON: Financial Troubles for a 3DCP Industry Leader?
In a ”Worker Adjustment & Retraining Notification Notices” (WARN) report issued by the Texas Workforce Commission, it states ...